Genotyping at the TNF-α and GNB3 loci represents an ideal tool for preventive medicine, in that individuals at risk of obesity and AMI can be identified early and their genetic predisposition could be counteracted through changes in lifestyle. This evidence concerns the gene GNB3 and obesity disorder.